In terms of OS, high GPSM2 expression was associated with poor OS prognosis in ACC (p = 5.9e-04), LIHC (p = 1.5e-05), LUAD (P = 3e-02), PAAD (p = 2.5e-03), MESO (p = 2.2e-05), and THCA (p = 3.1e-02) (Figure 4A). This evidence concerns the gene GPSM2 and adrenal cortex carcinoma.